| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0024-3205(99)00272-6 |
| P698 | PubMed publication ID | 10462078 |
| P2093 | author name string | Gribaldo L | |
| Marafante E | |||
| Mineo E | |||
| Neri MG | |||
| Pessina A | |||
| Raimondi A | |||
| Catalani P | |||
| Piccirillo M | |||
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| Conditions controlling the proliferation of haemopoietic stem cells in vitro | Q34162126 | ||
| Regulation of hemopoiesis by bone marrow stromal cells and their products | Q37925511 | ||
| The stromal cells' guide to the stem cell universe | Q40926883 | ||
| Modulation of EL-4 mouse lymphoma cell proliferation by macrophages and tumor related factors | Q41586319 | ||
| Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells | Q41648693 | ||
| In vitro study of pesticide hematotoxicity in human and rat progenitors. | Q52543103 | ||
| A colorimetric liquid culture assay of a growth factor for primitive murine macrophage progenitor cells | Q68189512 | ||
| Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes | Q68343168 | ||
| The growth of mouse bone marrow cells in vitro | Q70071283 | ||
| CFU-s and CFU-c proliferation after treatment of normal bone marrow cells with Ehrlich ascitic fluid | Q70492253 | ||
| Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning | Q72535465 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| CFU-GM | Q2931384 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 513-523 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM). | |
| P478 | volume | 65 |
| Q39614800 | A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells |
| Q38354283 | Alternative methods in toxicology: CFU assays application, limitation and future prospective |
| Q52608756 | Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. |
| Q52591382 | Dental pulp stem cells used to deliver the anticancer drug paclitaxel. |
| Q91603938 | Efficient lung cancer-targeted drug delivery via a nanoparticle/MSC system |
| Q33263087 | Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production |
| Q26825272 | Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy |
| Q38829699 | Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts |
| Q34113542 | Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy |
| Q35552693 | The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias |
Search more.